Originally posted by gringer
View Post
What I am looking for at this point is someone who has used an instrument reporting what it does right now. (This could be Oxford Nanopore.) So far, it looks like the only concrete claim of that sort is the lambda genome one. If the third hand reports are accurate in this respect. Are we absolutely sure the intent of that report was not -- "in principle, given the potential of this device, it could sequence both strands of a lambda genome in a single read"?
Yes, I realize there might be lots of data tied up by NDAs. Maybe there is high tier journal article embargo in effect that is preventing more disclosure? Oxford Nanopore may have their hands tied by British advertising regulations, not wanting to release 4% error data when they think they will hit 1% in a brief time span or some other issue. Does not matter, I think Rothberg's doubts are doubts we should all consider.
--
Phillip
Comment